ZANBELMA
Live / Registered — Registered (as of 07 Jun 2022)
What this means for you
Registered since 07 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79315744
- Registration number
- 6749428
- Mark type
- Stylized text
- Filed
- 26 May 2021
- Published for opposition
- 22 Mar 2022
- Registered
- 07 Jun 2022
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders
Owner
Prosecution history
- 11 Sept 2022 — NOTIFICATION PROCESSED BY IB
- 25 Aug 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Jul 2022 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 07 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 22 Mar 2022 — PUBLISHED FOR OPPOSITION
- 21 Mar 2022 — NOTIFICATION PROCESSED BY IB
- 02 Mar 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Mar 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 02 Mar 2022 — NOTICE OF PUBLICATION
- 16 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2022 — ASSIGNED TO EXAMINER
- 31 Jul 2021 — APPLICATION FILING RECEIPT MAILED
- 27 Jul 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jul 2021 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 15 Jul 2021 — SN ASSIGNED FOR SECT 66A APPL FROM IB